Drug intelligence / Profile preview

hydrochlorothiazide

Development stage
Approved
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Hydrochlorothiazide is a thiazide diuretic (water pill) used primarily to treat hypertension (high blood pressure) and edema (fluid retention) associated with conditions such as congestive heart failure, liver cirrhosis, kidney disorders including nephrotic syndrome and glomerulonephritis. It works by inhibiting sodium reabsorption in the distal convoluted tubule of the kidney via blockade of the sodium-chloride symporter. This action increases excretion of sodium and water in urine while reducing fluid volume in tissues and blood vessels. The drug was first approved by the FDA in 1959 and is widely prescribed both alone and as part of fixed-dose combination products with other antihypertensive agents.

Brand names
HydroDIURILEsidrixMicrozideApo-HydroAquazideBPZideDichlotrideEsidrexHydrochlorotHydroSaluricHypothiazidOretic
Other names
HCTZ
02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call